About
Novel medicines targeting infectious diseases
Areas of Focus
Categories
Biotech
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
556
By Phase
PHASE1: 4PHASE2/PHASE3: 1
By Status
COMPLETED: 4RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT07024589Lead Sponsor
First-in-Human Trial of Oral AN2-502998
PHASE1Recruiting
64 participants
Started: Aug 4, 2025 · Completed: Dec 31, 2025
NCT06089668Lead Sponsor
An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis
N/ACompleted
200 participants
Started: Nov 1, 2023 · Completed: Feb 2, 2025
NCT05995444Lead Sponsor
A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects
PHASE1Completed
24 participants
Started: Jun 5, 2023 · Completed: Aug 3, 2023
NCT05327803Lead Sponsor
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
PHASE2/PHASE3Terminated
177 participants
Started: May 20, 2022 · Completed: Dec 18, 2024
NCT05283746Lead Sponsor
A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function
PHASE1Completed
40 participants
Started: Feb 21, 2022 · Completed: Jun 27, 2022
Locations (1)
Headquarters
Menlo Park, CA, United States
Map
Loading map...